Form 8-K - Current report:
SEC Accession No. 0001079973-24-000367
Filing Date
2024-03-13
Accepted
2024-03-13 06:01:13
Documents
17
Period of Report
2024-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 39744
2 EXHIBIT 4.8 ex4x8.htm EX-4.8 13657
3 EXHIBIT 99.1 ex99x1.htm EX-99.1 6426
  Complete submission text file 0001079973-24-000367.txt   284333

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE scpx-20240311.xsd EX-101.SCH 3549
5 XBRL DEFINITION FILE scpx-20240311_def.xml EX-101.DEF 26579
6 XBRL LABEL FILE scpx-20240311_lab.xml EX-101.LAB 36527
7 XBRL PRESENTATION FILE scpx-20240311_pre.xml EX-101.PRE 25203
18 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 5436
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 24744491
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)